Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Inventory (2018 - 2025)

Historic Inventory for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $44.5 million.

  • TransMedics' Inventory fell 1466.1% to $44.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.5 million, marking a year-over-year decrease of 1466.1%. This contributed to the annual value of $46.6 million for FY2024, which is 524.25% up from last year.
  • TransMedics' Inventory amounted to $44.5 million in Q3 2025, which was down 1466.1% from $38.9 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Inventory peaked at $52.2 million during Q3 2024, and registered a low of $11.8 million during Q1 2021.
  • In the last 5 years, TransMedics' Inventory had a median value of $30.5 million in 2023 and averaged $31.0 million.
  • As far as peak fluctuations go, TransMedics' Inventory skyrocketed by 11468.09% in 2023, and later plummeted by 2014.14% in 2025.
  • Quarter analysis of 5 years shows TransMedics' Inventory stood at $14.9 million in 2021, then soared by 38.67% to $20.6 million in 2022, then soared by 114.68% to $44.2 million in 2023, then grew by 5.24% to $46.6 million in 2024, then decreased by 4.4% to $44.5 million in 2025.
  • Its Inventory stands at $44.5 million for Q3 2025, versus $38.9 million for Q2 2025 and $43.4 million for Q1 2025.